Return to Transcripts main page

Connect the World

Biden Transition Process Finally Begins; Trump Legal Team Still Claiming Fraud; Uganda Unrest; Interview with Dr. Soumya Swaminathan, WHO Chief Scientist, on the Race for a Vaccine. Aired 10-11a ET

Aired November 24, 2020 - 10:00   ET

THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.

[10:00:00]

(MUSIC PLAYING)

(BEGIN VIDEO CLIP)

UNIDENTIFIED FEMALE (voice-over): GSA administrator Emily Murphy has sent a letter to Joe Biden ascertaining that he is the winner of the 2020

election.

UNIDENTIFIED FEMALE: It is about time.

JIM ACOSTA, CNN CHIEF WHITE HOUSE CORRESPONDENT (voice-over): As one adviser put it, it's the end of the road for the president.

JEFF ZELENY, CNN SENIOR WASHINGTON CORRESPONDENT: Some history making choices, all of these nominees think they can get confirmed in the Senate.

BARACK OBAMA, FORMER PRESIDENT OF THE UNITED STATES: You're seeing a team develop that I have great confidence in.

(END VIDEO CLIP)

BECKY ANDERSON, CNN HOST (voice-over): We're going to be connecting you to Uganda, Nigeria, the cities of Tokyo, Paris and beyond this next couple of

hours as well as an interview with the WHO's chief scientist.

But first,, in America, all roads lead to Biden.

I'm Becky Anderson, hello and welcome to the program.

Well, this is it, day one. It's the first official day of the handover of the most powerful job on Earth from Donald Trump to Joe Biden three weeks

after the U.S. election.

A few hours ago, the head of what's known as the General Services Administration, who works for the president, sent out this letter,

informing President-Elect Joe Biden that the Trump administration is ready to begin the formal transition process, which means what exactly?

Well, to start with, it gives Biden's team access to millions of dollars to spend preparing to take over the government. And it allows federal agencies

to start working with Biden's team, on everything from employee background checks to the pandemic, which will mean that he is not starting from

scratch right after he takes over.

All of this, of course, usually par for the course in a regular peaceful transition of power in America. Well, this only finally happening at the

behest of the sitting president, of course. But he is not going down without a fight.

Donald Trump insisting that he will keep working to overturn what he sees as an unjust election and that he will never give in.

So a senior Republican close to the White House tells CNN, quote, "This is as close to a concession as you may get from Trump."

While fruitless squabbling over the inevitable goes on in the background, on this show, we are looking ahead. Meet Team Biden, his new cabinet packed

with people who are no strangers to Washington.

You will remember that Mr. Trump shunned such types, picking many outsiders for key positions. Here is Biden's lineup for now. And you will recognize

many faces from the Obama years. This cabinet then a reflection of who Biden is -- or at least who'd he like to be seen as.

It embodies a return to what will, to many, appear as a return to normal and predictable government, for better or for worse, in terms of

establishment thinking. But no matter how you cut it, the fact it's so historically diverse, definitely good news.

We will see the first female Treasury Secretary, the first female intelligence chief, the first Latino to head home security, amongst others.

You could argue, then, that normal is the new normal.

Let's talk about that with senior CNN's senior political analyst John Avlon, who is also the author of "Wing Nuts: Extremism in the Age of

Obama."

Thanks for being with us in what is Thanksgiving week, John, and coming in to work on your time off to give us your insights, we appreciate that.

Look --

JOHN AVLON, CNN SENIOR POLITICAL ANALYST: Absolutely.

ANDERSON: -- not everyone watching this show -- that's good. Not everybody watching this show around the world will applaud the restoration of normal

in America again. Be that as it may, it does seem that this transition is finally happening.

A period you describe as a Trumpian cocktail of incompetence and chaos, your thoughts?

AVLON: Yes, I mean, look, I think that that's actually close to objective assessment of what we've been seeing.

Look, on the international front, I think it's important for folks to realize there will be people who dislike what Joe Biden is doing.

But anybody who believes in the importance of international organizations has a lot to like in Joe Biden's world view and that of his secretary of

state designate Tony Blinken, because they are very committed to international alliances, contra to the Trump approach.

At the end of the day, I think one of the clear flow-throughs you see from this administration that is taking shape is Biden's commitment and

determination to make government work again.

It has not been working because of chaos and incompetence that has led to - -

[10:05:00]

AVLON: -- just to use one pointed example -- over a quarter of a million people dead in America because of COVID.

So that is a real contrast. The other one is you know, Tom Nichols wrote a book called "The Death of Expertise" several years ago. These are folks who

have deep expertise in their fields but also a collegial ability to work together.

And that's really important. This is not a team of rivals as much as it's a team of colleagues, who have deep credibility in their fields but have a

proven ability to work together. And that speaks well to the ability for Biden to hit the ground running, which is always important for an

administration but particularly in a pandemic.

ANDERSON: Our colleague, Steven Collinson, describes this lineup as far from flashy Team Biden. They are pragmatic centrists; no Kissinger or

Clintons. But he said, you will want to remember these names.

I want people to have a listen to Donald Trump two years ago, going after the so-called elites. And that's surely what he would call this new

cabinet. Let's have a listen.

(BEGIN VIDEO CLIP)

DONALD TRUMP (R), PRESIDENT OF THE UNITED STATES: Did you ever notice they always call the other side -- and they do this -- the elite. The elite.

Why are they elite?

I have a much better apartment than they do. I'm smarter than they are. I'm richer than they are. I became president and they didn't. And I'm

representing the greatest, smartest, most loyal, best people on Earth, the deplorables, remember that?

(END VIDEO CLIP)

ANDERSON: A whiff of a bygone era, nearly, John.

(LAUGHTER)

AVLON: An outgoing era; but, yes, look, I think it speaks to what BS the populist billionaire poser has been to from the very beginning. You have

all of these sycophants around him, including pretenders to the '24 campaign, if Trump doesn't suck up all the oxygen for them, a bunch of Ivy

League populists who like to rail against elites but themselves are absolutely quintessential elites.

I think what you're seeing with the Biden team today is people who believe in expertise and have worked together up the rungs of government. There are

a lot of firsts -- Janet Yellen, first female Treasury Secretary, which is a little insane but the first, she has been Fed chair and head of the

Council of Economic Advisers.

That deep expertise and the ability to work together, consistent with Joe Biden's vision, I think, is actually not elite so much as an attempt to

make government work again and take it back from sort of showboating outsiders, who have been squabbling and stabbing each other in the back.

And when they leave the administration, painting a very consistent picture of a president who is completely out of control and over his head and

disengaged, simultaneously, which is hard to do.

ANDERSON: John, let's be quite clear. Donald Trump, while allowing now for this transition to begin, is insisting that he will keep working to

overturn what he sees as an unjust election and that he will never give in.

We have seen a litany of accusations about fraud. His legal team, it seems, is unraveling in front of our eyes. Even Rush Limbaugh disappointed by what

he has seen from Donald Trump's legal team. My view is -- just have a listen to this.

(BEGIN AUDIO CLIP)

RUSH LIMBAUGH, TALK RADIO HOST: You call a gigantic press conference like that, one that lasts an hour and you announce massive bombshells, then you

better have some bombshells. There better be something at that press conference other than what we got.

I talked to so many people who were blown away by it, by the very nature of the press conference. They promised blockbuster stuff and then nothing

happened. And that's just -- that's not -- well, it's just not -- it's not good.

(END AUDIO CLIP)

ANDERSON: It does seem remarkable to hear that narrative from Rush Limbaugh, who has been such a staunch supporter of the Donald Trump

administration. Rudy Giuliani, it seems, will not give up.

Should we be asking why at this point?

AVLON: Well, look, you know, what Rush Limbaugh and other folks are confronting, as they're grasping for straws and reasons to believe, is the

fact that this was all a lie. You know, the people claiming that other folks are trying to steal the election were the ones trying to steal the

election.

[10:10:00]

AVLON: The only fraud was the one they were perpetrating on the American people by trying to undermine legitimacy of a democratic election,

lowercase D. And that's a sin that shouldn't be easily forgotten.

And I don't think people should get too many pats on the back for finally, after almost three weeks, following the rule of law and deep, embedded

American traditions.

But yes, there's going to be trouble because Donald Trump is stirring this up and trying to profit, still fundraising off these fictitious and

consistently failed legal claims, to profit once again off his supporters and to parlay it into some personal gain.

Because for this and for a lot of folks, this has been a game. But other folks take it very seriously. And that threat to the integrity of American

elections and our confidence in our democracy and a peaceful transfer of power is a very serious thing they are playing with, little more than a

dogged attempt to defend the president's fragile ego because he lost.

He lost fair, he lost square and they have failed consistently to put forward anything resembling evidence to the contrary, which is why they

have lost 40 cases to date and won one.

It's a legacy of failure and fraud. But some folks are still believing it and we need to find a way to reconcile again on a common set of facts

because that's not the way we traditionally have played ball in America. Other countries do that. And that's one hope for turning the page.

ANDERSON: It's a pleasure having you on, sir. It is an odd year. I know that so many will be spending Thanksgiving in a bubble, as it were.

Can you imagine me saying, you know, have a good bubble this time last year?

But that's what I'm going to say. Have a good bubble, sir. Thank you for joining us. Happy Thanksgiving.

AVLON: There's a lot to be Thanksgiving about. Thank you.

ANDERSON: John Avlon in the house.

There is so much more to get into with all of this and I will with former presidential campaign candidate turned CNN commentator, Andrew Yang. That

is coming up next hour.

And a little later we will connect you with some dark and baffling questions about the politics in the state of Florida. Several mystery

candidates did no campaigning and held no fundraisers. There's evidence to suggest they were shell candidates, who were planted by so-called dark

money.

(BEGIN VIDEO CLIP)

DREW GRIFFIN, CNN SR. INVESTIGATIVE CORRESPONDENT (voice-over): It was the closest of races. Incumbent Democrat Jose Javier Rodriguez lost his Florida

Senate seat by just 32 votes. The Republican challenger who won, Ileana Garcia, a founder of Latinos for Trump.

But there was a third candidate in this race, playing the role of spoiler. His name, Alex Rodriguez, sharing the same last name as the Democrat in the

race and promoted as a liberal.

Alex Rodriguez got more than 6,000 votes. Jose Rodriguez says the straw candidate cost him his seat by pulling away Democrat votes.

GRIFFIN: Have you ever met him, seen him, talked to him?

Has he been involved in any debates?

UNIDENTIFIED MALE: I didn't even know what he looked like until after the race and investigative reporters tracked him down.

(END VIDEO CLIP)

ANDERSON: More on that later in the show. Do stay with us for that.

Despite pleas to stay at home, millions of Americans are packing up and hitting the road two days ahead of that Thanksgiving holiday, many ignoring

warnings by health experts not to gather with loved ones as the coronavirus explodes across the country.

On Monday, United States set a record for hospitalizations for the 14th straight day. That number reaching more than 85,000. The situation making

for a solemn holiday for many families.

According to Johns Hopkins University, nearly 12.5 million Americans have been infected in all, well over a quarter of a million have died and it is

expected to get very much more -- very much worse.

A new model predicts the number of cases in the U.S. could soar to 20 million by January 20th. That, of course, is inauguration.

So, of course, many of us are asking, where is a vaccine?

Well, just hours ago Russia announced its COVID-19 vaccine is highly effective and will cost less than others on the market. The latest from

Moscow is after this.

And the World Health Organization's chief scientist joins us to talk about that new vaccine and all the latest coronavirus news.

Plus --

(BEGIN VIDEO CLIP)

DAVID MCKENZIE, CNN CORRESPONDENT (voice-over): As he secretly filmed as, below him, Kampala descended into days of chaos and death.

UNIDENTIFIED MALE: They couldn't listen to anyone. The only thing was to beat, tear gas and bullets.

ANDERSON (voice-over): The death toll in Uganda is up to 45.

[10:15:00]

ANDERSON: Police and the military are accused of firing into crowds to break up protests.

(MUSIC PLAYING)

(COMMERCIAL BREAK)

(MUSIC PLAYING)

ANDERSON: We've been tracking COVID-19 vaccine news, moving at lightning speed over the last few weeks. And now CNN has learned that the U.S.

regulatory body, the FDA, is asking its advisory committee to meet twice next month to review both the Pfizer and Moderna coronavirus vaccines.

Both, of course, showed great promise in late-stage trials. And if the FDA authorizes the vaccines, the CDC advisory committee will meet one to two

days later. Then, if and when CDC experts decide to recommend the vaccine, they will issue guidance to states. And finally vaccinations will be

distributed. That's the story, of course, in the U.S.

Meanwhile, Russia says that its Sputnik V vaccine is at least 91 percent effective and will cost less than the vaccines being developed by those

companies in the United States. CNN's Matthew Chance has the very latest from Moscow.

(BEGIN VIDEOTAPE)

MATTHEW CHANCE, CNN SENIOR INTERNATIONAL CORRESPONDENT: Becky, Russia's coronavirus vaccine, Sputnik V, is over 95 percent effective, according to

the latest interim data that's been released by its Kremlin-backed developers.

An update on the third phase human trials said that that high level of efficacy was observed 42 days after the first phase of the vaccine had been

administered; after 28 days, efficacy was put at 91.4 percent. Obviously, both those results need to be independently verified.

In the meantime, no unexpected adverse effects were reported among the trial participants, according, again, to the interim data. Russia says it's

pricing that vaccine at less than $10 a dose for international markets, making it one of the cheaper vaccine options that could soon become

available worldwide.

Sputnik V, remember, is controversial because it was the first vaccine back in August to be approved for public use in any country, even before human

trials had ended. Thousands of front line health care workers and teachers here in Russia have already been vaccinated with it, along with several

high profile political figures.

The Kremlin, though, says the Russian president himself, Vladimir Putin, has not taken the vaccine yet. The president cannot use an uncertified

vaccine, a spokesman told reporters earlier today. That, he, said would be impossible -- Becky, back to you.

(END VIDEOTAPE)

ANDERSON: That was Matthew Chance reporting.

When it comes to vaccines, our next guest says it's important for trials to continue because we shouldn't all think that we've got one or two and we

just stop everything. No, we need a variety of vaccines and it's possible that some will have longer protections than others.

[10:20:00]

ANDERSON: The chief scientist for the World Health Organization, Soumya Swaminathan, joins us now from India.

It's fantastic to have you on. I want to take a look at the big picture and then drill down, if you will.

Big picture, how do you feel about where we are at today in this race for a vaccine or vaccines?

DR. SOUMYA SWAMINATHAN, WHO CHIEF SCIENTIST: Hello, Becky. And thank you for having me.

Well, I would say that we are very encouraged, very optimistic and very happy and relieved to see the first few results coming out, really with the

proof of concept, that we can develop effective vaccines for this infection and, therefore, we can start looking at really beginning to end the

pandemic.

Now we have the tools. But we're still at the beginning of the journey. All we have seen is interim data, from quite a few companies now -- from

Pfizer, from Moderna, from Gamaleya in Russia and from AstraZeneca. It's very interim, very short term; follow-up is just a couple of months.

And that's why we need to continue with the studies to learn more about protection as we go on, longer-term, as well as safety.

(CROSSTALK)

ANDERSON: You rightly pointed out the big challenge is, of course, to now produce and distribute enough to save the world from this pandemic. Let's

discuss how indeed we do that.

Firstly, though, you've made some very good points here. There are some knowns at this point and quite a lot of unknowns.

What do we still need to find out at this point?

SWAMINATHAN: Yes. I think the knowns are that we know we picked the spike protein of this virus. Scientists picked that protein as a target for most

of the vaccines in development, the first set of them. That seems to be the right choice because we are now seeing some efficacy results coming out. So

that's the good news.

There are many different platforms, of course, being tested. We have the protein vaccines; we have the mRNA, the DNA vaccines, the viral vector

vaccines. So each of them might have, you know, different properties we don't know until we've done the trials and seen the data. We still don't

know really what this protective immunity against this virus looks like and we will find that out.

Now that we have trials, where some people are being protected, some have got infection, we can look at the immune response in these groups of

people, look at neutralizing antibodies, look at T-cell responses and begin to create what we call a surrogate of protection.

Then we know that, if you test somebody and you test their -- whether it's antibodies or T-cell responses, we can say whether that person is protected

or not.

And that's going to be important for future vaccine trials as well as, you know, to actually do a lot of other science.

We don't know what the duration of protection of these vaccines is going to be.

Is it going to be like flu vaccine, short lasting, needing a booster every year?

Or hopefully longer lasting. And the other thing we don't know, of course, is the protection in subgroups, people who are older. You know, some of

these vaccines would be safer for use in women, who are more likely to get pregnant, or in children.

And one other important point is does it actually block transmission?

What we've been looking at, what most of the trials fixed as their endpoint was the prevention of a disease, some traumatic disease. And, of course,

looking at severe disease because what we really want is to reduce death in severe disease.

But what would be ideal is a vaccine that actually stops you from getting the infection because then you're not going to spread it to anyone else.

And that's going to really then give us hope that we can perhaps, one day, you know, eradicate this infection. But we don't know these things as yet.

ANDERSON: Yes. Let's just listen to some of the thoughts of one of the lead developers of the AstraZeneca trial. I spoke to this professor, he is

from the Jenner Institute at Oxford University. Have a listen to this. This is what he told me.

(BEGIN VIDEO CLIP)

ADRIAN HILL, JENNER INSTITUTE, OXFORD UNIVERSITY: Even more excitingly, an endpoint we don't think any other group has looked at, which is to ask the

question, does the vaccine protect against being infectious?

In other words, most people who are infectious are actually asymptomatic in many countries. And to measure asymptomatic COVID, you need to swab people.

And we did that in literally thousands of people every week for months and months and months.

So we have the result of how well the vaccine protects you against asymptomatic COVID infection, which, of course, as you know, is

transmissible. So the initial data on that we're going to look at more carefully.

[10:25:00]

HILL: But again, it looks like we're getting significant, useful efficacy against asymptomatic carriage of this virus.

(END VIDEO CLIP)

ANDERSON: Very much speaking to your last point.

What are your thoughts on that development?

How likely is it that we will see it elsewhere?

SWAMINATHAN: Well, it makes you hopeful since it's been observed in one trial. And I know that other trials -- some of the other trials, anyway,

are looking at this endpoint, it's important to look at it.

And there have been multiple other secondary endpoints -- immunology, virology and so on. So I think it's very good. It's important to know if it

reduces the risk of severe disease and hospitalization and death.

But even better, it reduces these traumatic infections as well. So I think overall, the news in the last week to 10 days has been very, very

encouraging and something that everyone can really look forward -- something to get hopeful about, finally.

ANDERSON: Yes, good. Well, let's hear from the Qantas CEO now about mandating a vaccine for travel going forward. Have a listen.

(BEGIN VIDEO CLIP)

ALAN JOYCE, QANTAS CEO: For international travelers, that we will ask people to have a vaccination before they can get on the aircraft. Whether

you need that domestically, we will have to see what happens with COVID-19 on the market.

But certainly for international visitors coming out and people leaving the country, we think that is a necessity.

UNIDENTIFIED FEMALE: Is that something that you think will happen around the world, that we literally won't be able to travel anywhere unless we

provide proof of vaccination?

JOYCE: I think that's going to be a common theme in talking to my colleagues in other airlines around the globe.

(END VIDEO CLIP)

ANDERSON: That assumes, doesn't it, that every single person around the world can get hold of this vaccine, those who want to travel, of course,

and that they can get it as often as they might need it. All of these are unknowns at this point.

I wonder if you think that's either a good idea or possibly practical, what the Qantas CEO is telling us?

And further, how do you expect to see this roll out?

Not everyone will get access to a vaccine at the outset, will they?

I mean, let's be quite clear about this.

SWAMINATHAN: Absolutely, Becky. As you're rightly pointing out, I think they're going to see very short supplies of vaccines over the next six

months. And there's going to be a mad rush for them.

Our hope and our goal, as WHO and the COVAX partnership of Gavi and SEPI and WHO, our hope is that we're able to create access, we're able to get

whatever number of vaccines there are available.

We hope we can have them distributed around the world so we can protect those who are at the front lines, the most vulnerable who need to be

urgently protected rather than, you know, vaccinating entire populations of some countries while everyone else is waiting in line.

That's what we're working towards and we really hope that we're able to do that. Now whatever the circumstances, it's going to take a year to even

begin to cover 15 percent to 20 percent of the world's population if you take the entire world.

And that -- we believe that 20 percent should be the people at highest risk of either getting the infection or dying. They should be prioritized. It's

only in 2022 that we can begin to see a much wider vaccination program.

So mandatory vaccination for airline travel, if implemented, will lead to a lot of difficulties and problems. My take on this would be this is why we

have international health regulations.

As you know, the member states came together at WHO in 2005 and updated the international health regulations. It's being reviewed again as we speak.

And that's the kind of place I think to discuss rules around travel and trade and what countries should do because then it's negotiated, discussed.

Pros and cons are laid on the table and then member states together, countries come together and make a decision based on, you know, what's good

for public health.

ANDERSON: You talk about member states.

SWAMINATHAN: Yes.

ANDERSON: Sorry. Go on.

SWAMINATHAN: No, there are going to be many issues like this that are going to be discussed, also learning from this pandemic, whether the rules

need to be modified to face the next set of infections.

ANDERSON: Sure. You talk about member states and I have to just close this conversation with, you know, underlining the huge show of support from many

world leaders at G20 this week in Riyadh for the WHO. I understand that WHO scientists are receiving hate mail and threats, which is disgusting and

inexcusable.

[10:30:00]

ANDERSON: And my colleagues and I at CNN are extremely sorry for those of your team and those at the WHO, who are receiving that sort of mail.

Can you give us a sense of why people see the WHO as worth attacking as a health body?

Does this make sense to you in any way?

SWAMINATHAN: I don't understand it, Becky. But perhaps one reason is that it's easy to attack us. We don't -- we can't retaliate. We don't retaliate.

We are a science-based organization. We try to stick with the science.

We may have got it wrong a couple of times. I think everyone has. In a new situation when you're learning all the time we learn from that and we move

on and we do our best.

I'd like to, I think, repeat what my colleague, Dr. Mike Ryan said yesterday. He said that, you know, we only thought that you needed to be

intelligent to be a scientist. But it turns out you need to be brave as well because, as you said, we've been attacked.

We've been vilified, we've been trolled on social media, all about things which normally one would sit down and have a constructive, you know, debate

around.

But unfortunately, in this pandemic, perhaps because emotions have been so high all around, these relationships many times seem to have broken down.

But having said that, we have had amazing support from people around the world, from scientists around the world.

So overall, I would say that it's been positive; despite, you know, the kind of things that you described.

ANDERSON: And with that, we've going to have to leave it there because I have to take a break. We thank you very much indeed for joining us today.

Chief scientist at the WHO. Taking a break. Back after this.

(MUSIC PLAYING)

(COMMERCIAL BREAK)

ANDERSON: Today we are connecting you to protests around the world for new details on the shooting of protesters in Nigeria to outrage over a

controversial new law in France.

First I want to turn our focus to Uganda. Police say at least 45 people have been killed during protests following the arrest of pop star turned

presidential candidate Bobi Wine.

Wine running against the long-time incumbent. CNN's David McKenzie has been covering the protests and unrest for us. He joins us tonight with more.

What is the latest as you understand it, David?

MCKENZIE: Becky, the latest is, as you say, at least 45 people killed in days of some of the worst protests we have seen in Uganda in several years.

The security forces have said that -- have blamed these protests on, quote, "hooligans;" sometimes they're calling them terrorists.

[10:35:00]

MCKENZIE: But our reporting suggests something else in that there were innocent civilians that were killed.

(BEGIN VIDEOTAPE)

MCKENZIE (voice-over): As he secretly filmed as, below him, Kampala descended into days of chaos and death.

UNIDENTIFIED MALE: They couldn't listen to anyone. The only thing was to beat, tear gas and bullets. Many were shot in the legs and their back or in

the stomach and the heads.

MCKENZIE (voice-over): He was afraid to move beyond the building stairwell, afraid if the soldiers spotted him, that they would kill him.

He's still afraid, only agreeing to speak to us if we concealed his identity.

UNIDENTIFIED FEMALE: These guys are shooting in front of the --

(CROSSTALK)

UNIDENTIFIED FEMALE: Oh, my God.

MCKENZIE (voice-over): Widely circulated videos show soldiers and plainclothes gunmen firing high caliber rifles into crowded urban slums.

UNIDENTIFIED FEMALE: Mummy, I'm very scared.

MCKENZIE (voice-over): At least 45 people were killed, hundreds more injured. Uganda's worst violence in years sparked by the arrest of Bobi

Wine, a pop star turned presidential candidate in January's election.

FRED ENANGA, UGANDAN POLICE SPOKESMAN: These events were not just impromptu actions, but part of a loosely coordinated campaign.

MCKENZIE (voice-over): A police spokesman told CNN that there were quite a lot of incidents where their officers, quote, "allegedly conducted

themselves unprofessionally and such cases are being investigated."

But he claims some officers used bullets to disperse crowds in self- defense. The Ugandan military did not respond to our repeated calls.

UNIDENTIFIED MALE: (INAUDIBLE) free and fair elections because they're being arrested, are being tortured and unarmed citizens are being killed.

MCKENZIE: Bobi Wine is charged with contravening strict COVID-19 rules. But he says his arrest is an attempt by authorities to stop his popular

campaign against President Yoweri Museveni, who has held an iron grip on power for more than 30 years.

UNIDENTIFIED MALE: This election is very different because it is a generational fight. President Museveni, who is approaching 80 years old, is

facing a young man who is half his age. It is a fight between the past and the future.

MCKENZIE (voice-over): Yusuf's (ph) family says he wasn't political at all, he was just going out to buy milk.

MCKENZIE: Where were his injuries?

Where was he shot?

UNIDENTIFIED MALE: He was shot from the back.

MCKENZIE: Shot in the back?

UNIDENTIFIED MALE: Because you couldn't be alive -- because no one was helping him -- the people were on the scene, they said he stayed there

almost 2.5 hours while he was losing blood until he died.

MCKENZIE (voice over): He was buried on Friday, just a few days before what would've been his 21st birthday.

UNIDENTIFIED MALE: We need peace in Uganda. We need democracy in Uganda.

MCKENZIE (voice-over): Right now, Uganda has neither.

(END VIDEOTAPE)

MCKENZIE: Elections are coming up in January, Becky, and many are worried that this is just the start of what could be a very difficult time for

Uganda and a broader issue of a very young population and an aging leader, which we see in many different parts of the continent -- Becky.

ANDERSON: David McKenzie is in Johannesburg. Thank you, David.

In Nigeria, a similar theme of the government attacking protesters and then wanting to tell a different tale. Just ahead, we will bring you more of

CNN's exclusive reporting on the attack that killed peaceful protesters in Nigeria last month. And we will look at the questions raised by this

surveillance.

Plus --

(BEGIN VIDEO CLIP)

UNIDENTIFIED MALE: (Speaking French).

MELISSA BELL, CNN CORRESPONDENT (voice-over): The French filmmaker David Dufresne says that his recent documentary about police brutality simply

could not have been made if the law had been in place.

ANDERSON (voice-over): There's outrage in France over a new proposed law that, critics claim, will make it harder to hold police to account. The

whole world is connected to everything we see in it. Much more on that is just ahead.

(END VIDEO CLIP)

(MUSIC PLAYING)

(COMMERCIAL BREAK)

[10:40:00]

(MUSIC PLAYING)

ANDERSON: If that last story didn't move you, here is another one guaranteed to warm your cold, cold heart. Chicago's Shedd Aquarium is

closed to visitors right now but four of its penguins got to get out and see the world. They visited Soldier Field ahead of a Chicago Fire football

match.

(WORLD SPORTS)

[11:00:00]

END